/ EN
2025-01-10 00:00 China Policy & Regulation Industrial Planning Translated from EN

Shanghai Sets BCI Clinical Application Timeline

Summary Shanghai's science commission issued a BCI industry action plan centering on medical-grade scenarios, with a clinical timeline for invasive and semi-invasive products.
Why it matters The most clinically focused local policy in China, committing semi-invasive products to first-in-country clinical application and a largely localized upstream supply chain by 2030 — a strong signal for device makers and investors

BCIwiki (bciwiki.com) — The Shanghai Municipal Science and Technology Commission (上海市科学技术委员会) issued the Action Plan for Cultivating the Brain-Computer Interface Future Industry in Shanghai (2025-2030), document Hu-Ke [2025] No. 5, on January 10, 2025.

The plan sets a clinical timeline: before 2027, Shanghai aims to move more than 5 invasive and semi-invasive brain-computer interface products through medical device type testing and clinical trials, have semi-invasive products reach clinical application first in China, and attract or cultivate more than 5 independent innovators with core BCI technology plus more than 10 backbone supply-chain companies; before 2030, BCI products are to reach full clinical application, the upstream supply chain is to be largely localized, and a national-level BCI industry cluster is to be established. Invasive and semi-invasive work centers on medical-grade scenarios — motor control, speech synthesis, treatment of neurological diseases and vision restoration — while non-invasive development targets rehabilitation, education, entertainment, smart living and manufacturing.

Compiled by BCIwiki from public sources

Sources · 1
stcsm.sh.gov.cn 2025-01-10

Shanghai Municipal Science and Technology Commission timeline

2026-09 Shanghai Aims to Partially Restore Sight With BCIs by 2030 All entries →
Read original ↗
Suggest a correction Revisions · none / EN
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About